Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2012-04-16

Clinical Trial Update: Azithromycin in Control of Trachoma II [Phase 4]

View source ↗

Summary

A Phase 4 trial of azithromycin for the control of trachoma was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Azithromycin (azithromycin)

Snippet

Sponsor: University of California, San Francisco | Conditions: Trachoma | Phase 4 | Status: WITHDRAWN